Clinical Trial Materials
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
Catalent, BrainStorm Enter ALS Drug Manufacturing Pact
Catalent will undertake the transfer of the manufacturing process to, and provide future cGMP clinical supply of NurOwn from its Houston facility.Contract Pharma Staff 10.22.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Greenwich Lifesciences Completes Manufacturing of GP2
The active ingredient is ready for its planned Phase III clinical trial.Contract Pharma Staff 10.13.20
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
Abzena Invests $60M Into cGMP Manufacturing Capacity
New facility in San Diego houses a process development laboratory and two new cGMP manufacturing cleanrooms.Contract Pharma Staff 10.08.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Rentschler Biopharma Enters COVID-19 Vax Agreement with BioNTech
Will serve as CDMO partner for drug substance manufacturing of BNT162b2.Contract Pharma Staff 10.08.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Preclinical Outsourcing
Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200
Paves the way towards getting OCU200 in the clinic by first half of 2022.Contract Pharma Staff 10.06.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Cobra Biologics to Manufacture Plasmids for COVID-19 Vax Trial
Collaboration will ensure GMP production of material for Phase I clinical trial of Scancell’s DNA vaccine against SARS-CoV-2.Contract Pharma Staff 10.05.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Fill/Finish | Industry News
Novavax, Par Sterile Products Enter COVID-19 Vax Mfg. Pact
Par Sterile's Rochester facility began production of NVX-CoV2373 final drug product, with initial batches to be used in Novavax' Phase III trial.Contract Pharma Staff 09.25.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
T-knife, Catalent Sign Tech Transfer and Mfg. Pact for Cell Therapy
Catalent to provide technology transfer and cGMP clinical manufacture of T-knife’s T1367 T-cell receptor program at its site in Gosselies, Belgium.Contract Pharma Staff 09.21.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Process Development
Samsung Biologics Inks Service Pact with Panolos Bioscience
Will provide cell line development, process development, and clinical material manufacturing for PB101, an Fc-fusion protein to treat solid tumors.Contract Pharma Staff 09.17.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Takeda Opens R&D Cell Therapy Mfg. Facility in Boston
Will support expansion of next-generation clinical programs, including five collaborative oncology cell therapy programs entering trials.Contract Pharma Staff 09.15.20
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
CMAB Biopharma and Laekna Therapeutics Collaborate
Enter strategic agreement for LAE005 global development and commercialization partnership.Contract Pharma Staff 09.10.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
CD19 CAR-T Therapy Manufactured Using Lonza’s Cocoon Platform
MOH approves Cocoon Platform to manufacture a CD19 CAR-T cell immunotherapy for Phase II clinical trial for B-cell malignancies.Contract Pharma Staff 09.09.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
JanOne Prepares for GMP Production
Bottling and labeling of clinical trial batches are expected to begin in early October led by Eurofins CDMO.Contract Pharma Staff 09.08.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
CNS Achieves Key Milestones in Berubicin Dual-track Mfg. Strategy
CNS and Pii complete successful lab simulation of the lyophilization cycle and Pii is expected to begin manufacturing Berubicin during 3Q20.Contract Pharma Staff 09.04.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Fill/Finish | Industry News
Catalent Invests $50M at Bloomington Facility
To install an additional high-speed vial filling line to support growing pipeline of clinical programs and commercial launches at the site.Contract Pharma Staff 09.02.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic
COVID-19 clinical trial planned for Q1 2021 supported by Canadian Government.08.28.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances
Sutro Biopharma Achieves Merck KGaA Clinical Supply Milestone
Delivers GMP clinical trial supply to Merck KGaA for Phase 1 trial of M1231, a bispecific ADC for the treatment of solid tumors.Contract Pharma Staff 08.25.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
JanOne Readies for Clinical GMP Manufacturing Run
JAN101 formulation ready for Phase 2b peripheral artery disease trials and for potential treatment of COVID-19 vascular inflammation.Contract Pharma Staff 08.20.20
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals
To manufacture biopharmaceuticals at clinical development stage.Contract Pharma Staff 08.20.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
ANA Therapeutics Partners with Quotient Sciences
Will manufacture ANA001 as a potential treatment for COVID-19.Contract Pharma Staff 08.13.20
